Filtros : "Emirados Árabes Unidos" "FCF" Removidos: "Indexado no Current Contents" "Oliveira, Ricardo Pinheiro de Souza" "1928" Limpar

Filtros



Refine with date range


  • Source: Current Medicinal Chemistry. Unidades: FCF, IQ

    Subjects: FÁRMACOS, ANALGÉSICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BORGES, Lara Gimenez et al. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673310050240821054652. Acesso em: 11 nov. 2024.
    • APA

      Borges, L. G., Alves, T. N. de O., Vassiliades, S. V., & Parise Filho, R. (2024). Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry. doi:10.2174/0109298673310050240821054652
    • NLM

      Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 11 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
    • Vancouver

      Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 11 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
  • Source: Current Medicinal Chemistry. Unidade: FCF

    Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 11 nov. 2024.
    • APA

      Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
    • NLM

      Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 11 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
    • Vancouver

      Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 11 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
  • Unidades: IFSC, FCF

    Assunto: QUÍMICA MÉDICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Current Topics in Medicinal Chemistry. . Sharjah: Bentham Science. . Acesso em: 11 nov. 2024. , 2024
    • APA

      Current Topics in Medicinal Chemistry. (2024). Current Topics in Medicinal Chemistry. Sharjah: Bentham Science.
    • NLM

      Current Topics in Medicinal Chemistry. 2024 ;[citado 2024 nov. 11 ]
    • Vancouver

      Current Topics in Medicinal Chemistry. 2024 ;[citado 2024 nov. 11 ]
  • Source: Letters in Drug Design & Discovery. Unidade: FCF

    Subjects: GLIOMA, SISTEMA NERVOSO CENTRAL

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, Thais Batista et al. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, v. 21, p. 948-960, 2024Tradução . . Disponível em: https://doi.org/10.2174/1570180820666230131111033. Acesso em: 11 nov. 2024.
    • APA

      Fernandes, T. B., Yang, R., Ferreira, G. M., Souza, P. O. de, Lopes, V. G., Toledo, M. F. Z. J., et al. (2024). Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, 21, 948-960. doi:10.2174/1570180820666230131111033
    • NLM

      Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2024 ; 21 948-960.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1570180820666230131111033
    • Vancouver

      Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2024 ; 21 948-960.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1570180820666230131111033
  • Source: Current Nutrition and Food Science. Unidade: FCF

    Subjects: HORMÔNIOS, ÁCIDOS GRAXOS, AMINOÁCIDOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MAGALHÃES, Hilton César Rodrigues et al. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review. Current Nutrition and Food Science, v. 19, n. 3, p. 246-261, 2023Tradução . . Disponível em: https://doi.org/10.2174/1573401318666220527123341. Acesso em: 11 nov. 2024.
    • APA

      Magalhães, H. C. R., Garruti, D. S., Gandra, E. A., & Purgatto, E. (2023). Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review. Current Nutrition and Food Science, 19( 3), 246-261. doi:10.2174/1573401318666220527123341
    • NLM

      Magalhães HCR, Garruti DS, Gandra EA, Purgatto E. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review [Internet]. Current Nutrition and Food Science. 2023 ; 19( 3): 246-261.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1573401318666220527123341
    • Vancouver

      Magalhães HCR, Garruti DS, Gandra EA, Purgatto E. Effect of postharvest treatments on the biosynthesis of fruit volatile compounds: a literature review [Internet]. Current Nutrition and Food Science. 2023 ; 19( 3): 246-261.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1573401318666220527123341
  • Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF

    Subjects: HOMEOSTASE, TUBERCULOSE, ÁCIDO FÓLICO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VASSILIADES, Sandra Valeria et al. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, v. 23, n. 17, p. 1711-1732, 2023Tradução . . Disponível em: https://doi.org/10.2174/1389557523666230206163154. Acesso em: 11 nov. 2024.
    • APA

      Vassiliades, S. V., Borges, L. G., Giarolla, J., & Parise Filho, R. (2023). Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, 23( 17), 1711-1732. doi:10.2174/1389557523666230206163154
    • NLM

      Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389557523666230206163154
    • Vancouver

      Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389557523666230206163154
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: MEDICAMENTO, METABOLISMO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CUPPOLONI, Andréa et al. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, v. 23, n. 12, p. 1081-1089, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230207120752. Acesso em: 11 nov. 2024.
    • APA

      Cuppoloni, A., Silva, J. V. da, Snape, T. J., Lal, S., & Giarolla, J. (2023). 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, 23( 12), 1081-1089. doi:10.2174/1568026623666230207120752
    • NLM

      Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026623666230207120752
    • Vancouver

      Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026623666230207120752
  • Source: Letters in Drug Design & Discovery. Unidade: FCF

    Subjects: NEOPLASIAS PULMONARES, NANOTECNOLOGIA, RESISTÊNCIA MICROBIANA ÀS DROGAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AWASTHI, Rajendra et al. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, v. 20, n. 5, p. 499-516, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180819666220510133408. Acesso em: 11 nov. 2024.
    • APA

      Awasthi, R., Singh, A. K., Mishra, G., Maurya, A., Dhiman, N., Kharkwal, H., et al. (2023). Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles. Letters in Drug Design & Discovery, 20( 5), 499-516. doi:10.2174/1570180819666220510133408
    • NLM

      Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1570180819666220510133408
    • Vancouver

      Awasthi R, Singh AK, Mishra G, Maurya A, Dhiman N, Kharkwal H, Sharma B, Jha NK, Dua K, Pinto T de JA, Kulkarni GT. Diagnosis and clinical aspects of lung cancer: a special emphasis on drug targeting to cancer cells through nanoparticles [Internet]. Letters in Drug Design & Discovery. 2023 ; 20( 5): 499-516.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1570180819666220510133408
  • Unidades: IFSC, FCF

    Assunto: QUÍMICA MÉDICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Current Topics in Medicinal Chemistry. . Sharjah: Bentham Science. . Acesso em: 11 nov. 2024. , 2023
    • APA

      Current Topics in Medicinal Chemistry. (2023). Current Topics in Medicinal Chemistry. Sharjah: Bentham Science.
    • NLM

      Current Topics in Medicinal Chemistry. 2023 ;[citado 2024 nov. 11 ]
    • Vancouver

      Current Topics in Medicinal Chemistry. 2023 ;[citado 2024 nov. 11 ]
  • Source: Current Organic Chemistry. Unidade: FCF

    Subjects: DOENÇA DE CHAGAS, SÍNTESE ORGÂNICA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MORAIS, Pedro Alves Bezerra e TROSSINI, Gustavo Henrique Goulart. Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, v. 27, n. 4, p. 243-247, 2023Tradução . . Disponível em: https://doi.org/10.2174/1385272827666230418100932. Acesso em: 11 nov. 2024.
    • APA

      Morais, P. A. B., & Trossini, G. H. G. (2023). Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, 27( 4), 243-247. doi:10.2174/1385272827666230418100932
    • NLM

      Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1385272827666230418100932
    • Vancouver

      Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1385272827666230418100932
  • Source: Current Topics in Medicinal Chemistry. Unidades: FMVZ, FCF

    Subjects: PLANTAS MEDICINAIS, MEDICINA ALTERNATIVA, FITOQUÍMICA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RABELO, Ana Carolina Silveira et al. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications. Current Topics in Medicinal Chemistry, v. 23, n. 23, p. 2197-2213, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230606162556. Acesso em: 11 nov. 2024.
    • APA

      Rabelo, A. C. S., Noratto, G. D., Borghesi, J., Fonseca, A. S., Cantanhede Filho, A. J., Carneiro, F. J. C., et al. (2023). Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications. Current Topics in Medicinal Chemistry, 23( 23), 2197-2213. doi:10.2174/1568026623666230606162556
    • NLM

      Rabelo ACS, Noratto GD, Borghesi J, Fonseca AS, Cantanhede Filho AJ, Carneiro FJC, Silva ALA, Miglino MA. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 23): 2197-2213.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026623666230606162556
    • Vancouver

      Rabelo ACS, Noratto GD, Borghesi J, Fonseca AS, Cantanhede Filho AJ, Carneiro FJC, Silva ALA, Miglino MA. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 23): 2197-2213.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026623666230606162556
  • Source: Current Drug Targets. Unidade: FCF

    Subjects: FLAVONOIDES, MEDICAMENTO, DOENÇAS NEGLIGENCIADAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PONE, Boniface Kamdem e FERREIRA, Elizabeth Igne. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1389450123666220309093827. Acesso em: 11 nov. 2024. , 2022
    • APA

      Pone, B. K., & Ferreira, E. I. (2022). Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/1389450123666220309093827
    • NLM

      Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389450123666220309093827
    • Vancouver

      Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389450123666220309093827
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: PLASMODIUM, MALÁRIA, RNA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PARREIRA, Kleber Simônio et al. Contribution of transcriptome to elucidate the biology of Plasmodium spp. Current Topics in Medicinal Chemistry, v. 22, p. 169-187, 2022Tradução . . Disponível em: https://doi.org/10.2174/1568026622666220111140803. Acesso em: 11 nov. 2024.
    • APA

      Parreira, K. S., Scarpelli, P., Lima, W. R., & Garcia, C. R. da S. (2022). Contribution of transcriptome to elucidate the biology of Plasmodium spp. Current Topics in Medicinal Chemistry, 22, 169-187. doi:10.2174/1568026622666220111140803
    • NLM

      Parreira KS, Scarpelli P, Lima WR, Garcia CR da S. Contribution of transcriptome to elucidate the biology of Plasmodium spp [Internet]. Current Topics in Medicinal Chemistry. 2022 ; 22 169-187.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026622666220111140803
    • Vancouver

      Parreira KS, Scarpelli P, Lima WR, Garcia CR da S. Contribution of transcriptome to elucidate the biology of Plasmodium spp [Internet]. Current Topics in Medicinal Chemistry. 2022 ; 22 169-187.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026622666220111140803
  • Source: Current Drug Targets. Unidade: FCF

    Subjects: TRYPANOSOMA CRUZI, COMPOSTOS HETEROCÍCLICOS, ANTIPROTOZOÁRIOS, DOENÇAS NEGLIGENCIADAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PONE, Kamdem Boniface et al. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, v. 23, n. 1, p. 33-59, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450122666210412125643. Acesso em: 11 nov. 2024.
    • APA

      Pone, K. B., Dalhatou, S., Paumo, H. K., Seru, L. M. K., & Ferreira, E. I. (2022). Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, 23( 1), 33-59. doi:10.2174/1389450122666210412125643
    • NLM

      Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389450122666210412125643
    • Vancouver

      Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389450122666210412125643
  • Source: Protein and Peptide Letters. Unidade: FCF

    Subjects: ZIKA VÍRUS, PEPTÍDEOS, MODELAGEM MOLECULAR

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, João Vitor da et al. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, v. 29, p. 901-910, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929866529666220919143316. Acesso em: 11 nov. 2024.
    • APA

      Silva, J. V. da, Savino, D. F., Hirata, M. H., Ferreira, G. M., & Giarolla, J. (2022). Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, 29, 901-910. doi:10.2174/0929866529666220919143316
    • NLM

      Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/0929866529666220919143316
    • Vancouver

      Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/0929866529666220919143316
  • Source: Current Drug Targets. Unidade: FCF

    Subjects: DOENÇAS NEGLIGENCIADAS, ANTIMALÁRICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, v. 22, p. 379-398, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389450121666201228122239. Acesso em: 11 nov. 2024.
    • APA

      Boniface, P. K., & Ferreira, E. I. (2021). The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, 22, 379-398. doi:10.2174/1389450121666201228122239
    • NLM

      Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389450121666201228122239
    • Vancouver

      Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389450121666201228122239
  • Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF

    Assunto: FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 11 nov. 2024.
    • APA

      Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
    • NLM

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389557521666210226145328
    • Vancouver

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1389557521666210226145328
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: RECEPTORES, MEDICAMENTO, NUCLEOTÍDEOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GARCIA, Célia Regina da Silva e SILVA, Robson Coutinho. Receptors in health and diseases: purinergic signaling in parasites [Editorial]. Current Topics in Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/156802662103210101154231. Acesso em: 11 nov. 2024. , 2021
    • APA

      Garcia, C. R. da S., & Silva, R. C. (2021). Receptors in health and diseases: purinergic signaling in parasites [Editorial]. Current Topics in Medicinal Chemistry. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/156802662103210101154231
    • NLM

      Garcia CR da S, Silva RC. Receptors in health and diseases: purinergic signaling in parasites [Editorial] [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21( 3): 169-170.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/156802662103210101154231
    • Vancouver

      Garcia CR da S, Silva RC. Receptors in health and diseases: purinergic signaling in parasites [Editorial] [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21( 3): 169-170.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/156802662103210101154231
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: PLASMODIUM FALCIPARUM, MALÁRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEREIRA, Pedro Henrique Scarpelli e PEREIRA, Lucas Borges e GARCIA, Célia Regina da Silva. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites. Current Topics in Medicinal Chemistry, v. 21, p. 171-180, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026620666200826122716. Acesso em: 11 nov. 2024.
    • APA

      Pereira, P. H. S., Pereira, L. B., & Garcia, C. R. da S. (2021). Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites. Current Topics in Medicinal Chemistry, 21, 171-180. doi:10.2174/1568026620666200826122716
    • NLM

      Pereira PHS, Pereira LB, Garcia CR da S. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 171-180.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026620666200826122716
    • Vancouver

      Pereira PHS, Pereira LB, Garcia CR da S. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 171-180.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026620666200826122716
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 11 nov. 2024.
    • APA

      Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
    • NLM

      Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026621666210728094804
    • Vancouver

      Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 11 ] Available from: https://doi.org/10.2174/1568026621666210728094804

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024